Skip to main content

Does carboplatin cause neuropathy?

Medically reviewed by Leigh Ann Anderson, PharmD. Last updated on Sep 25, 2024.

Official answer

by Drugs.com

Peripheral neuropathy is uncommon when conventional doses of carboplatin are used, but patients over 65 years of age may be at higher risk. Carboplatin may be associated with peripheral neuropathy in about 4% to 15% of patients.

If carboplatin is combined with other neurotoxic cancer treatments, or used at higher doses or for prolonged periods, the risk of more severe neuropathy may increase.

Peripheral neuropathy due to cancer treatments (chemotherapy) can cause symptoms of pain, weakness, and numbness from nerve damage, usually in the hands and feet. Symptoms of neuropathy may persist, or even worsen, for months after drug treatment is stopped.

Carboplatin is a platinum-based chemotherapy agent, but neuropathy symptoms with carboplatin treatment tend to be mild in most cases. Anticancer drugs that are commonly associated with more severe neuropathy include the platinum agents cisplatin and oxaliplatin.

What do studies say?

In clinical studies when ​​a carboplatin regimen was compared to a cisplatin regimen in 393 patients for the treatment of ovarian cancer, peripheral neuropathy occurred in 16% of patients receiving the carboplatin regimen compared to 42% in the cisplatin regimen arm, a significant difference.

Patients older than 65 years of age or previously treated with cisplatin may be at a greater risk of neuropathies, in up to 10% of patients. However, in 70% of patients pretreated with cisplatin who had already developed peripheral neurotoxicity, their symptoms did not worsen with carboplatin therapy.

Other neurologic complications of carboplatin therapy may include retinal (eye) toxicity that may lead to vision loss and ototoxicity that may lead to hearing loss or ringing in the ears (tinnitus), although these side effects tend to be more common with cisplatin.

This is not all the possible side effects that may occur with carboplatin. Talk with your doctor about any possible side effects before treatment with this medicine.

Related questions

Learn More:

Carboplatin: Side Effects, Warnings and What to Avoid

This is not all the information you need to know about carboplatin for safe and effective use and does not take the place of talking to your doctor about your treatment. Review the full carboplatin information here, and discuss this information and any questions you have with your doctor or other health care provider.

References

Read next

Is small cell or non-small cell lung cancer worse?

Generally, small cell lung cancer (SCLC) is worse than non-small cell lung cancer (NSCLC). SCLC accounts for about 10-15% of people who have lung cancer and is the most aggressive form of lung cancer. SCLC usually starts in the breathing tubes (bronchi), and although the cells are small, they grow very quickly and create large tumors. Early on in the course of the disease, there are rarely any symptoms. If caught early (limited-stage disease) 20-25% of people can be potentially cured. Extensive SCLC is more difficult to treat. Continue reading

Is non-small cell lung cancer hereditary?

A hereditary family history of lung cancer is one of the many risk factors for developing non-small cell lung cancer. About 8% of lung cancers are thought to be inherited or linked to gene changes, but smoking and air pollution remain the primary causes of lung cancer. Continue reading

How aggressive is non-small cell lung cancer?

Non-small cell lung cancer (NSCLC) tends to spread more slowly than small cell lung cancer (SCLC). About 80% of all lung cancers are diagnosed as NSCLC. Some forms of NSCLC do grow rapidly, such as large cell undifferentiated carcinoma and large cell neuroendocrine carcinoma. Lung cancer most commonly spreads to the liver, brain, bones or adrenal glands. Continue reading

Related medical questions

Drug information

Related support groups